Morgan Stanley’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.4M Sell
1,486,926
-485,196
-25% -$8.3M ﹤0.01% 2569
2025
Q1
$126M Buy
1,972,122
+980,467
+99% +$62.6M 0.01% 1088
2024
Q4
$121M Buy
991,655
+38,551
+4% +$4.69M 0.01% 1127
2024
Q3
$119M Sell
953,104
-1,670,257
-64% -$209M 0.01% 1118
2024
Q2
$414M Buy
2,623,361
+1,734,928
+195% +$274M 0.03% 513
2024
Q1
$115M Sell
888,433
-1,871,865
-68% -$242M 0.01% 1089
2023
Q4
$266M Buy
2,760,298
+1,904,854
+223% +$184M 0.01% 977
2023
Q3
$104M Sell
855,444
-120,906
-12% -$14.7M 0.01% 1033
2023
Q2
$112M Buy
976,350
+86,844
+10% +$9.95M 0.01% 1019
2023
Q1
$123M Buy
889,506
+432,453
+95% +$59.6M 0.01% 945
2022
Q4
$59.2M Buy
457,053
+60,786
+15% +$7.88M 0.01% 1368
2022
Q3
$43.8M Sell
396,267
-21,439
-5% -$2.37M 0.01% 1427
2022
Q2
$31.3M Buy
417,706
+47,190
+13% +$3.54M ﹤0.01% 1797
2022
Q1
$28.9M Buy
370,516
+133,013
+56% +$10.4M ﹤0.01% 1740
2021
Q4
$21.4M Sell
237,503
-101,766
-30% -$9.16M ﹤0.01% 2081
2021
Q3
$31.4M Buy
339,269
+14,573
+4% +$1.35M ﹤0.01% 1668
2021
Q2
$25.2M Buy
324,696
+132,095
+69% +$10.3M ﹤0.01% 1903
2021
Q1
$14.4M Sell
192,601
-103,755
-35% -$7.73M ﹤0.01% 2273
2020
Q4
$50.5M Buy
296,356
+92,845
+46% +$15.8M 0.01% 1096
2020
Q3
$28.6M Sell
203,511
-8,169
-4% -$1.15M 0.01% 1218
2020
Q2
$33.9M Sell
211,680
-128,831
-38% -$20.7M 0.01% 1065
2020
Q1
$33.3M Buy
340,511
+51,082
+18% +$5M 0.01% 958
2019
Q4
$37.3M Buy
289,429
+80,818
+39% +$10.4M 0.01% 1140
2019
Q3
$15.7M Sell
208,611
-65,789
-24% -$4.96M ﹤0.01% 1685
2019
Q2
$41.7M Buy
274,400
+110,095
+67% +$16.7M 0.01% 950
2019
Q1
$19.6M Sell
164,305
-2,877
-2% -$343K 0.01% 1463
2018
Q4
$18.2M Sell
167,182
-21,393
-11% -$2.33M 0.01% 1538
2018
Q3
$30.5M Sell
188,575
-121,631
-39% -$19.6M 0.01% 1312
2018
Q2
$41M Sell
310,206
-212,378
-41% -$28.1M 0.01% 1027
2018
Q1
$38.7M Sell
522,584
-305,453
-37% -$22.6M 0.01% 1097
2017
Q4
$46.1M Buy
828,037
+566,915
+217% +$31.5M 0.01% 1005
2017
Q3
$11.8M Buy
261,122
+82,938
+47% +$3.76M ﹤0.01% 2104
2017
Q2
$6.01M Sell
178,184
-11,926
-6% -$402K ﹤0.01% 2664
2017
Q1
$5.63M Sell
190,110
-19,174
-9% -$568K ﹤0.01% 2746
2016
Q4
$5.74M Sell
209,284
-274,263
-57% -$7.52M ﹤0.01% 2849
2016
Q3
$29.7M Sell
483,547
-484,180
-50% -$29.7M 0.01% 1167
2016
Q2
$18.5M Buy
967,727
+522,049
+117% +$9.96M 0.01% 1483
2016
Q1
$8.7M Buy
445,678
+311,893
+233% +$6.09M ﹤0.01% 1983
2015
Q4
$5.16M Buy
133,785
+24,477
+22% +$944K ﹤0.01% 2635
2015
Q3
$3.51M Sell
109,308
-11,753
-10% -$377K ﹤0.01% 2961
2015
Q2
$3.68M Buy
121,061
+48,123
+66% +$1.46M ﹤0.01% 3060
2015
Q1
$969K Buy
72,938
+1,102
+2% +$14.6K ﹤0.01% 4155
2014
Q4
$1.04M Sell
71,836
-29,493
-29% -$427K ﹤0.01% 4120
2014
Q3
$2.14M Sell
101,329
-8,447
-8% -$178K ﹤0.01% 3380
2014
Q2
$3.27M Buy
109,776
+22,930
+26% +$683K ﹤0.01% 3066
2014
Q1
$2.09M Buy
86,846
+29,782
+52% +$716K ﹤0.01% 3375
2013
Q4
$1.16M Sell
57,064
-282,756
-83% -$5.76M ﹤0.01% 3811
2013
Q3
$16.1M Buy
339,820
+266,087
+361% +$12.6M 0.01% 1405
2013
Q2
$2.8M Buy
+73,733
New +$2.8M ﹤0.01% 2867